Hypoadiponectinemia is independently associated with impaired glucose tolerance and coronary artery disease in non-diabetic men, suggesting its utility as a risk marker.
No takes yet. Share an insight, caveat, or question.
Adiponectin may mark CAD and IGT risk in non-diabetic men; leaves open its value for risk stratification pending prospective data.
Otsuka et al. (2007) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: